Login to Your Account



Financings Roundup

Metabasis Advancing Internal Programs With $41M Funding

By Karen Pihl-Carey


Tuesday, October 4, 2005
As it prepares to bring two more of its internally discovered products into the clinic, Metabasis Therapeutics Inc. raised $41.3 million in a private placement of common stock and warrants. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription